Deepak Nitrite has received revision in credit ratings from ICRA for bank facilities worth Rs 490 crore and commercial paper of Rs 200 crore as under Long term rating – ICRA AA; Positive rating reaffirmed and outlook revised from Stable Short term rating – ICRA A1 The companys subsidiary Deepak Phenolics received upgrade in credit ratings for bank facilities worth Rs 75627 crore as under […]
Softrak Venture Investment will hold a meeting of the Board of Directors of the Company on 26 March 2022
Alembic Pharmaceuticals announced that it has received final approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA for Lacosamide Tablets USP 50 mg 100 mg 150 mg and 200 mg The approved ANDA is therapeutically equivalent to the reference listed drug product RLD Vimpat Tablets 50 mg 100 mg 150 mg and 200 mg of UCB Inc Lacosamide Tablets […]
IIFL Finance has approved the buy-back of its SERIES01 USD 400M 5875PCT NOTES DUE 20APR2023 Notes listed on the Singapore Exchange Securities Trading SGX-ST from its eligible noteholders as set out in the tender offer memorandum up to a maximum purchase amount of US$50000000 nominal value and shall further initiate the cancellation of Notes following the settlement date
Future Lifestyle Fashions announced that an Extra Ordinary General Meeting EGM of the Company will be held on 20 April 2022
Modulex Construction Technologies announced that an Extra Ordinary General Meeting EGM of the Company will be held on 13 April 2022
Adani Green Energy has extended its Construction Financing Framework to USD 164 billion by raising a USD 288 million facility for its under-construction renewable asset portfolio through definitive agreements signed with a group of leading international lenders The facility will initially finance the 450 MW hybrid portfolio of solar and wind renewable projects that AGEL is setting up in Rajasthan India In March 2021 AGEL […]
SMS Pharmaceuticals has received a non-exclusive license through the Medicines Patent Pool to manufacture nirmatrelive an oral anti-viral COVID-19 medicine developed by Pfizer to increase broad access of treatment in 95 low- and mid-income countries
Ceinsys Tech will hold a meeting of the Board of Directors of the Company on 26 March 2022
Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 21 March 2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
